Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717989 · ClinicalTrials.gov registry record
Study to Evaluate the Prospective Payment System
A clinical trial, sponsored by Amgen.
- Completed
- Registry status
- 2,248
- Enrollment target
NCT01717989: Completed study, sponsored by Amgen.
NCT01717989 is a clinical trial that has completed, run by Amgen. The registered enrollment target is 2,248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01717989 has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 2,248 participants
- Enrollment target
Study Summary
To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services' (CMS') policy \[End Stage Renal Disease (ESRD) Prospective Payment System (PPS)\] to bundle reimbursement for all dialysis services. Specifically, to describe CMS ESRD PPS quality performance measures for dialysis centers over time.
Primary Outcome
The percentage of participants within each small dialysis organization (SDO) facility with hemoglobin \< 10 g/dL over time. Percentage of participants meeting the criteria at the facility-level were calculated for each facility first and then summarized across facilities as a continuous variable, weighted by the number of participants in a facility.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,248 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-09 |
What the finished NCT01717989 record still lists
NCT01717989 is an observational study that tracks outcomes without assigning an intervention. Its 2,248 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01717989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01717989 about?
NCT01717989 is a clinical study titled "Study to Evaluate the Prospective Payment System". To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services' (CMS') policy \[End Stage Renal Disease (ESRD) Prospective Payment System (PPS)\] to bundle reimbursement for all dialysis service...
What is the current status of trial NCT01717989?
This trial is currently completed. The enrollment target is 2,248 participants. The study started on 2010-06. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01717989?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia